About Us
The University of Michigan Hepatology Program is one of the oldest liver programs in the country. The Program recently celebrated its golden jubilee with the inauguration of the Keith Henley Professorship. Dr. Henley was first to describe alanine aminotransferase (ALT) in serum, which is used throughout the world as a diagnostic tool for liver injury. The Hepatology Program was founded in 1954 under the leadership of Dr. Henley, who, along with Dr. Jeremiah Turcotte (the T of the CTP [Child-Turcotte-Pugh] score that is used to assess severity of liver disease), established the Liver Transplant Program in 1985.
The Hepatology Program faculty is committed to patient education and physician training. The Program has trained a majority of the transplant hepatologists practicing in Michigan and the Midwest.
The Hepatology Program currently offers a one-year Transplant Hepatology Fellowship for candidates who have completed an ABIM-certified three-year Gastroenterology Fellowship.
Our full-time faculty consists of 12 hepatologists with diverse expertise in many liver diseases. They are actively engaged in clinical, translational, and basic science research and are nationally and internationally recognized leaders in viral hepatitis, drug-induced liver disease, liver transplantation, and liver cancer.
